Ray Dalio, Jim Simons, and Paul Tudor Jones are battling it out over the Magnificent 7

The final edition of the 13F series features three of the world's best known investors - each with their own unique style.
Hans Lee

Livewire Markets

For our last in this week's 13F series, we thought we'd examine three great investors in one fell swoop. The reason we are analysing these three investors is because all of them are making big bets in one specific theme - the Magnificent Seven mega-cap tech stocks. But none of them are making identical moves to each other. 

Bridgewater Associates Founder (and former CIO) Ray Dalio is famed for his views on geopolitics, and macroeconomics, and for inventing the "All Weather" approach to investing. His largest holdings appear to reflect that - a barbell bet between a major emerging markets ETF and an ETF tracking the S&P 500. But at the individual stock level, Dalio has made two moves inside the Magnificent Seven. Dalio's latest 13F filing has 740 holdings.

Meanwhile, veteran technical trader Paul Tudor Jones is one to hedge his bets. Not only does he have more than 2,200 holdings according to his latest 13F filing, but he also likes to make trades - often. Between newly initiated put options, call options, and regular long positions, Tudor Jones made 673 moves between the current reporting period and the previous reporting period. That's a lot of movement. He's also been making moves in the Magnificent Seven - and several stand out. 

Finally, famed quantitative trader and mathematician Jim Simons has made his fair share of moves. More than 3,600 holdings are in his 13F filing and Simons used last quarter to buy and sell many of the Magnificent Seven names. But his largest individual holding isn't a Magnificent Seven name. 

Without further ado, here are the three final investors in our series and their major 13F filings. 

Ray Dalio's Q3 13F - Major Buys

Stock Name Stock Code Portfolio Addition (%)
Schlumberger Ltd. NASDAQ: SLB  0.28%
Broadcom NASDAQ: AVGO  0.27%
Netflix NASDAQ: NFLX  0.22%
Meta Platforms NASDAQ: META  0.18%
Cisco Systems NASDAQ: CSCO  0.17%

Ray Dalio's Q3 13F - Major Sells

Stock Name Stock Code Portfolio Subtraction (%)
Johnson & Johnson Co NASDAQ: JNJ  0.69%
Vanguard EM ETF NYSE: VWO  0.56%
Visa NYSE: V  0.31%
Starbucks NASDAQ: SBUX  0.27%
SPDR S&P 500 ETF Trust ASX: SPY  0.26%

Ray Dalio's Top 5 Holdings

Stock Name Stock Code Portfolio Allocation (%)
iShares Core MSCI EM ETF NYSE: IEMG  5.52%
iShares Core S&P 500 ETF NYSE: IVV  5.31%
Procter & Gamble NYSE: PG  4.23%
Coca Cola NYSE: KO  3.04%
Costco NASDAQ: COST  2.83%

Key Takeaway: Dalio appears to be leaning into the EM and Big Tech trades but continues to prefer consumer staples. In the last quarter, two of his major buys were Netflix and Meta Platforms while a third - Broadcom - is considered one of the top ways to play the semiconductor trade. I wonder what Michael Burry would say to that. 

In its place, Dalio has sold Johnson & Johnson but kept Procter & Gamble, Coca-Cola, and Costco. As the Danish analyst Andreas Steno Larsen has been known to say, "go long what people need, go short what people want."

Paul Tudor Jones' Q3 13F - Major Buys

Stock Name Stock Code Portfolio Addition (%) Note:
Activision Blizzard NASDAQ: ATVI  2.40%
Seagen NYSE: SGEN  2.29% (PUT)
Invesco QQQ Trust NYSE: QQQ  1.80%
Seagen NYSE: SGEN 1.71% (LONG)
Splunk NASDAQ: SPLK  1.69%

Paul Tudor Jones' Q3 13F - Major Sells

Stock Name Stock Code Portfolio Subtraction (%) Note:
NVIDIA NASDAQ: NVDA  4.42% (CALL)
Life Storage NYSE: LSI  0.87%
NVIDIA NASDAQ: NVDA 0.84% (LONG)
Meta Platforms NASDAQ: META  0.68%
Alphabet NASDAQ: GOOGL  0.62%

Paul Tudor Jones' Top Holdings

Stock Name Stock Code Portfolio Allocation (%) Note
Seagen NYSE: SGEN 2.98% (PUT)
Activision Blizzard NASDAQ: ATVI 2.85%
Seagen NYSE: SGEN 2.49% (LONG)
Invesco QQQ Trust NYSE: QQQ 1.80% (CALL)
Splunk Inc NASDAQ: SPLK 1.69%

Key Insight: Paul Tudor Jones' filings are far more complicated. Not least because, like many technical and quant traders, Tudor Jones uses put and call options which makes compiling this list more challenging. 

The two big things for my money are the off-loading in NVIDIA stock and the fact that he's selling Meta when Ray Dalio is buying it. It should be said that Tudor Jones is not known for his short investing, so the NVIDIA call option sale maybe because it's reached his price target (aka, he wants to take his profits while he can). 

Jim Simons Q3 13F - Major Buys

Stock Name Stock Code Portfolio Addition (%)
Microsoft NASDAQ: MSFT  0.60%
Berkshire Hathaway  NASDAQ: BRK/A  0.60%
Netflix NASDAQ: NFLX  0.59%
Vertex Pharmaceuticals NASDAQ: VRTX  0.34%
Nike NYSE: NKE  0.32%

Jim Simons' Q3 13Fs - Major Sells

Stock Name Stock Code Portfolio Subtraction (%)
Meta Platforms NASDAQ: META 1.82%
Tesla NASDAQ: TSLA  0.48%
Alphabet NASDAQ: GOOGL  0.39%
Boeing NYSE: BA  0.38%
Lululemon NASDAQ: LULU  0.32%

Jim Simons' Top Holdings

Stock Name Stock Code Portfolio Allocation (%)
Novo-Nordisk A/S ADS CPH: NOVO-B 2.52%
Apple NASDAQ: AAPL  1.23%
Palantir NYSE: PLTR  1.19%
VeriSign NASDAQ: VRSN  1.07%
Berkshire Hathaway NASDAQ: BRK/A 1.05%

Key Insight: Several things stand out in this list. Just like Tudor Jones, Jim Simons has been selling Meta Platforms and Alphabet - so much so that it was his top sell and third-largest sell by portfolio allocation last quarter respectively. But unlike Tudor Jones and like Dalio, Simons has shifted some cash into Netflix. 

The company has continued to beat (low) earnings and paid subscriber expectations from analysts, allowing the share price to surge from beaten-down levels. 

Finally, Simons' largest holding is one that does not sound like the other two. Novo Nordisk has gained a lot of attention in recent months as the manufacturer of Ozempic, the diabetes treatment that has garnered a lot of press around the world for its high demand (by diabetics and non-diabetics).

Note: To see the entire 13F filings of our profiled investors, you can go to 13f.infowhere you can also find comparisons between each quarter. As always, 13F filings only mandate the declaration of long positions and the filings don’t require investors to reveal the price paid, strike price or expiration date of options purchased. Our top five holdings information comes to us from Whale Wisdom.

........
Livewire gives readers access to information and educational content provided by financial services professionals and companies (“Livewire Contributors”). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors.

31 stocks mentioned

1 fund mentioned

Hans Lee
Senior Editor
Livewire Markets

Hans is one of Livewire's senior editors, specialising in global markets and economics. He is the creator and presenter of Livewire's "Signal or Noise".

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment